[lH]Hexachlorocyclohexane (HCH) was synthesized by chlorination of [lß]benzene prepared by catalytic tritiation of benzene with tritiated water. The isomers of HCH were separated by adsorption chromatography on silica gel. In order to determine the covalent binding to DNA, [lß]HCH was administered to male mice by oral gavage, and liver DNA was isolated via cbromatin. The specific radioactivity of the DNA was nonnalized by the dose administered and expressed in the molar units of the Covalent binding index, CBI = DNA damage/dose = (J.tmol bound HCH/mol DNA nucleotide)/(mmol HCH administered/kg body weight). CBI values of -0.2 were found 10 h after the administration of alpha-and gamma-HCH. Enzymatic digestion of the DNA to the nucleosides and h.p.l.c. analysis revealed that -400Jo of the radioactivity co-migrated with the natural nucleosides. At elution volumes known to contain the more lipophilic carcinogen-nucleoside adducts, -10% of the radioactivity could be detected. The remaining 50% of th,e radioactivity eluted with the front, representing a mixture of oligonucleotide-HCH adducts and/or hydrophilic degradation products which were strongly bot not covalently associated with intact DNA. Therefore, a true CBI of 0.02-0.1 must be expected both for alpha-and gamma-HCH. This CBI is by a factor of 10 5 -10 6 below the value found with the strongest DNAbinding carcinogens like aflatoxin B 1 or dimethylnitrosamine and is unlikely to be decisive for the liver tumor induction in mice because of the foUowing additional findings: (i) 8oth isomers gave rise to similar Ievels of DNA darnage although the alpha-isomer is a much morepotent tumor inducer. This similarity was seen not only at the time of mäximum binding but up to 10 days after oral administration; (ü) three mouse strains with apparently different susceptibility to tumor induction by gamma-HCH could not be distinguished with respect to DNA binding; (iü) the Ievei of DNA binding of alpha-HCH (CBI = 0.02-0.1) is more than three orders of magnitude lower than would be expected if the mechanism of tumor induction was by genotoxicity mediated by DNAbinding. For a preliminary investigation on a potential stimulatory effect on liver DN A replication and ceU division, [l~]thymidine was admlnistered i.p. 3.5 h before sacrifice of the [lß]HCH-treated mice. The alpha-isomer was found to be more potent than the gamma-isomer in this respect. Taken together, our data allow the conclusion that the non- 
Introduction
Hexachlorocyclohexane (HCH)* comprises of a group of isomers of which the gamma-isom~r, later called lindane, has very useful pesticidal activity (1) . HCH have become of great public concem because the lindane batches used in the late forties contained appreciable concentrations of alpha-and beta-isomer. The alpha-isomer was found to induce liver tumors in rats and mice (2) , the beta-isomer·was found to have very low biodegradability and to be deposited in animal fat. Although the lindane batches used since the fifties were at least 99% pure gamma-isomer, a new discussion arose from controversial findings of a liver tumor-inducing potential of lindane itself.
Chemically-induced tumors are now thought to be the result of a DNA darnage succeeded by appropriate promotion (3) . Most chemieals exert their activity by covalent interaction of a reactive metabolite with DNA in the target organ and are therefore called genotoxic. The metabolism of HCH involves the formation of oJefms (I) and a subsequent epoxidation could result in the generation of an electrophiJic species.
Another group of tumor-enhancing agents, viz cocarcinogens and promoters, do not themselves react with DNA but apparently modulate one or s.everal out of a variety of biochemical and biological steps related to the process of tumor formation. Such activities arealso d.iscussed for HCH. For instance, alpha-HCH was found to enhance the proliferation of putative preneoplastic cells in rat liver (4) , and all HCH isomers are known tobe inducers of drug-metabolizing enzymes (I), the alpha-isomer being more potent than lindane.
It was the aim of this study to provide more infonnation about the mechanism of tumor induction by HCH. Forthis reason it was examined whether the isomers of HCH can be metabolized in vivo to reactive metabolites able to reach and bind to liver DNA or whether the hepatocarcinogenicity is rather due to non-genotoxic effects. It seemed especially worthwhile to investigate whether the clear d.ifference between the alpha-and the gamma·isomer with respect to biological effects and tumor induction . (2) was reflected in their ability to bind to DNA, and whether the apparent difference in susceptibility of different strains of mice to the carcinogenicity of gamma-HCH (5-7) can be based upon different Ievels of DNA bind.ing.
Materials and Methods

Chemieals and opparatus
Reagents without specified distributor were of the highest purity available from Merck, Darmstadt, FRG. Hydroxylapatite {HA) (DNA-Grade, Bio-Gel HTP) was purchased from Bio-Rad, Richmond, CA, sodiurn dodecyl sulfate (SOS) from Sigma, St. Louis, MO, Nonidet P 40 (NP 40) and copper oxide (wire form) from BDH Chemieals Ltd., Poole (8) . 16 .5 mmol chlorine gas were generated from Oxidation of 33 mmol silver chloride with 12 g potassium dichromate in 100 ml concentrated sulfuric acid and trapped by cooling with liquid nitrogen. The [lH]benzene and chlorine were lyophilized into a 2S ml quartz round-bottom flask prefilled with 5 m1 carbon tetrachloride. The mixturewas kept at -2S°C to -30°C for 2 h under irradiation at 254 nm. Solvent and unreacted benzene were distilled off and the residue containing -500lo of the radioactivity was extracted with petroleum ether {30-4.S°C boiling point) to bring the alpha-, gamma-, delta· and epsilon isomers into solution. The specific radioactivity of HCH was calculated from results derived in preliminary synthesis with a trace arnount of radioactivity and was found to be -1 Ci/mmol. The products were identified as HCH by mass spectrometry. The isomers were separated by chromatography on silica gel 60 aecording to Granger and Zwilling (9) . The radiochemical purity of the isolated isomers was > 99Cifo, the isomeric purities were checked by semipreparative gas chromatography. Column: OV 17, 20'/o methylphenylsilicone, 200 cm; column temperature: 175°C; injection temperature: 210°C, Nr pressure: 0.9 kglcmZ) and was found tobe 98% (alpha-HCH). 92% (gamma-HCH; 8% epsilon-HCH) and 95% (delta·HCH; S% epsilson-HCH). Beta-HCH was prepared by recrystallisation from a chlorofonn extract of the residue. The radiochemical purity was > 99%, the isomeric purity was 96% (4% epsilon-HCH). 20 .mJ isoamyl alcohol, ftlled up to I Iiter under stirring with warmed liquid phenol) was added and proteins were eruacted in the centrifuge tube under extensive shaking for 10 min on a shaking machine. The resulting suspension was separated into two layers by centrifugation for J S min at 20 (XX) g. The CIP phase was saved for protein isolation, the super· natant aqueous layer was first decanted and then pipetted into a new polypropylene centrifuge tube and was extracted once more with 10 m1 CIP. The aqueous solution was ~racted twice with 2S m1 ether in a 250 ml separating funnel for the removal of trace amounts of phenol, was left standing overnight at room temperature and was applied to an HA column. Dry HA (I g/g Ii ver) of special batches tested for high absorptivity of DNA was suspended ovemight in fl.ltered MUP (8 M urea, 0.2A M sodium phosphate buffer pH 6.8), the slurry was swirled gently and wa.S left untouched for 10 min. The ftne panides were decanted. The rema.ining slurry was poured into 2S x 120 mm glass colwnns and the MUP was Iet run off. The aqueou~ nucleic acid solution was loaded on the column and the elution was monitared at 260 nm. Proteins were washed from the column with ftltered MUP at a now rate of 1-2 ml/min by gravity until the transmission had retumed to background value.
Animals and treatments
To avoid a mixing of the eluants the column was Iet run dry before purging the urea from the column with two bed volumes 14 mM sodium phosphate buffer, pH 6.8. DNA was eluted with 0.48 M sodium phosphate buffer, pH 6.8, and -20 ml of the DNA solution were collected. From here on, extreme caution is required not to use glassware, equipment or facilities which are also used for proc:edures involving high radioactivity Ievels. The sample was diafyz. ed at4°Cagainst 10 Iiter 0.2 M NaCI ovemight. DNAwas precipitated by ad· ding 2 volumes ethanol and keeping at -20°C for at least 12 h. The DNA was centrifuged for 20 min at 1000 g, the supematant was decanted and DNA was dried in vacuo for 2-3 h. The highly purified DNA was dissolved in 10 mM MgCI 21 Isolation of chromatin protein. I ml of the ftrst CIP extract from a DNA isolation of 10 g liver was shaken with -5 ml I O!o SOS in 14 mM sodium phosphate buffer, pH 6.8. Protein was precipitated with 25cmJ acetone and washed S times by redissolving in 2 ml I% SOS and acetone precipitation.
The fmal protein sample in I% SOS was diluted with water to 0.1 DJo SOS, was precipitated by the addition of 2 volumes acetone and was stored at -20"C ovemight. After a centrifugation at 300 g, the supematant was decanted and the protein residue was freed from acetonein vacuö for -15 rnin. Protein was dissolved in 2 ml1% SOS in 14 mM sodium phosphate buffer, pH 6.8, overnight and the solution was diluted with water to a ftnal concentration of 1.4 mM sodium phosphate buffer. The amount of protein was determined with the Folin reagent. 1-4 ml containing -0.5 mg protein/ml were used for the liquid scintillation counting.
Isolation of HCH metabolites
The supernatant of the fii'St acetone precipitation of chromatin protein from lhe CIP pha.se was dried in vacuo. About 7507o of the radioactivity in the CIP phasc could be d.i.ssolved in 10 mM Mg0 1 , 10 mM Tris!HO, pH 7.0 and was loaded on a Lichrosorb RP 18 column also used for the analysis of nudeosides by h.p.l.c. (see below).
Water-soluble metabolites were obtained from the aqueous solution after the first CIP extraction of chromatin homogenate. DNA was precipita.ed by the addition of 2 volumes ethanol and the supematant was dried in vacuo.
After dissolving the residue in 10 mM MgCiz 10 mM Tris/HCI, pH 7.0 the sample was analysed by h.p.l.c.
H.p.l.c. analysis of the nudeosides
DNA (1-2 mg/ml) in 10 mM MgCI 2 , 10 mM Tris/HCI, pH 7.0 was digested enzymatic:ally by the method described by King although the former is a markedly more potent carcinogen. This is the rrrst indication to postulate that DNA binding cannot be the decisive activity for the tumor-inducing potential of the HCH's. This hypothesis is also supported by the fmding that the delta-isomer which has never been found to induce tumors (16) also revealed a CBI of 0.16 (Table II) . The beta-isomer did not give rise to detectable DNA radioactivity (Table II) . In order to check whether a difference between the gammaand the alpha-isomer might be found at later times after the administration, the time dependence for the DNA binding was investigated. Figure 1 shows that the liver-DNA radioactivity reached the same plateau Ievel of about CBI = 0.5 after lO days. The time-dependent increase was faster in the frrst three days with the gamma-isomer, in accordance with the somewhat faster metabolism (17) . lt was also checked whether the absorption from the gastro-intestinal tract of the relatively high doses of chemical was different for the two isomers. This was not the case because it was found that the whole liver contained 2.1% and 2.2DJo of the radioactivity dose of the gamma-and the alpha-isomer, respectively, one day after the oral administtation.
Results
Comparison of isomers
Comparison of mouse strains
An additional hint for whether DNA binding could be the main mode of tumorigenic action of HCH should be obtained from studies with strains of mice that are of apparently different susceptibility to liver tumor induction by the gamma-isomer. The results given in Table 111 show that the three strains used aU gave rise to similar CBI values although NMRI mice (CBI = 0.28) were found to be Jess susceptible to the tumorigenic action of gamrna-HCl than B6C3F1 mice 
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Contribution of contaminations to the DNA radioactivity
It was assumed above that the DNA radioactivity was due entirely to DNA-HCH adducts. Other sources, such as biosynthetic incorporation of radiolabelled breakdown products of HCH entering the pool of DNA precursors, noncovalently bound HCH metabolites or protein contaminations might contribute all or a fraction of the radioactivity measured on the DNA. Any of these influences would make our argument for a non-mutagenic mode of action of HCH even stronger. A number of control experiments were per- Table IV show that chromatin protein was also racliolabelled, 10 h after [lH]HCH administration. The specific activity was 42-to 68-fold and 33-to 44-fold higher in protein as compared with DNA for the gamma-, and the alpha-isomer, respectively. Protein contamination of DNA was shown to be lower than 0.20/o as determined with radiolabelling of chromatin protein in vivo with PH]Iysine or [3 5 S]methionine . Protein contaminations cannot therefore contribute substantially to the radioactivity measured on the DNA.
Cantamination of DNA by non-covalently bound HCH metabolites. The control experiment where DNA was precipitated at different steps of the purification procedure showed that neither ether extraction nor dialysis resulted in a reduction of the specific [ 3 H]activity of DNA. This means that both lipophilic and hydrophilic metabolites had been removed completely from the DNA during the entire isolation procedure and that the DNA had been purified to constant specific activity.
Nucleoside analysis
Separation of the deoxynucleosides by h.p.l.c. after enzymatic digestion of üver DNA of alpha-and gamma-[3H]-HCH treated NMRI rnice (10-h-point) revealed that -30-400/o of the radioactivity eluted together with the optical density of the natural deoxynucleosides (Figure 2 ). This radioactivity is therefore most probably due to biosynthetic incorporation of breakdown products, for instance tritiated water. At a later elution time, a small ( -100/o of the radioactivity) but significant amount of radioactivity was detected. This is the region known to contain the more lipophiüc nucleoside-carcinogen adducts. The . fonnation of a nucleoside-HCH adduct therefore is highly probable. Up to SOOJo of the radioactivity of the DNA eluted in the frrst two fractions. This radioactivity can be due to DNA not completely degraded i.e., due to oligonucleotides which could still carry HCH adducts.
The samerelative distribution of radioactivity among the three different elution regions was found with a duplicate DNA sample isolated 10 h after the administration of gamma-[lJI]-HCH and with a DNA pooled from 1-day, 3-day, and 5-day mice.
In order to further exclude the possibility that HCH metabolites non-covalently bound to DNA could be responsible for the presumed adduct peak in fraction 16 and 18 for the gamma-and the alpha-isomer, respectively, metabolites isolated from the liver of a gamma-[3H]HCH-treated mouse > .... were analysed on the same h.p.l.c. system as used for the nucleosides. Figure 3 shows that the hydrophilic metabolites eluted in the frrst three fractions. Since this is the region which also contained radioactivity in the h.p.l.c. analysis of the DNA nucleoside it canriot be excluded that such metabolites were closely but non-covalently associated with DNA. The association must have been so strong that the dialysis did not remove them and only upon enzymatic degradation of the DNA were they released.
Lipophilic metabolites eluted at a retention time of -SO min. No radioactivity could be detected at retention times between 24 min and 48 min. These data indicate that the radioactivity peaks eluting after -35 min represent HCHdeoxynucleoside-adducts and not metabolites set free during the hydrolysis of the DNA.
True covalent DNA binding
The control experiments described above have revealed that biosynthetic incorporation of radiolabel into DNA has taken place and that hydrophilic metabolites might have been strongly but non-covalently associated with DNA. For a calculation of a true CBI, these contributions have to be deducted from the values given in Tables I-III. A reduction by a factor of -2 or 10 results, for the case where all earlyeluting radioactivity is regarded as oligonucleotide-HCH adducts or for the case where only the nucleoside-HCH adduct peak is considered. On a most conservative approach, therefore, a CBI of < 0.1 results.
·
Protein binding
In our experiments on DNA binding we also detennined the Ievel of non-extractable radioactivity in chromatin protein. This was done in a first place in order to detennine whether contamination of DNA with protein of high specific radioactivity might simulate DNA binding. The proteinbinding values are also low on an absolute Ievel upon comparison with standard carcinogens (15) , and, there was again no difference in protein binding between the two isomers (fable IV) or between the different strains of mice (fable V).
Rate of DNA synthesis
The animals received, 3.5 h before sacrifice, an i.p. Table VI show a tendency for the more potent alpha-isomer to induce a higher rate of DNA synthesis. 1t should be pointed out that these data were obtained from the identical animals used for the detennination of DNA binding by [lH]HCH ('fable 1), where the alpha-isomer was even slightly less effective than the gamma-isomer. 
Discussion
The previous section has provided good qualitative evidence for a DNA-HCH adduct. A comparison among strains and isomers makes it highly unlikely, however, that this type of genotoxic activity is the decisive mode of tumorigenic action. In addition, a quantitative analysis of the Ievel of DNA binding favours a non-genotoxic mode of tumorigenic action. A quantitative correlation of CBI versus carcinogenic potency expressed in TD 50 units (i.e., the daily dose estimated to induce a turnor in 500Jo of the animals treated for life), has shown that CBI of the order of 103-lot are found with strong genotoxic carcinogens, of 100 for moderate carcinogens and of 1-10 for weak carcinogens (18) . Since alpha-HCH has to be classified as a moderate turnor-inducing agent with an approximate TD 50 value of 0.1 mmol/kg/day for mause liver, a CBI for liver DNA of -102 would be required if its mode of action was by DNA binding.
The measured value of < 0.1 is one thousand times lower.
Among the many possible mechanisms of tumorigenic activity not related to DNA binding two aspects were amenable to an assay within the present experimental set-up. Frrstly, binding to protein and the concomitant cytotoxicity might be envisaged. Our results showed, however, that protein binding cannot be an important contribution to the proposed nonmutagenic mode of turnor induction.
Another possibility for a non-mutagenic mode of action, the Stimulation of cell division, was also tested simultaneously with the determination of DNA binding. These results gave some indication for a higher activity of the alpha-isomer although the experimental set-up was not ideal for the determination of this activity. It has been shown in rats that the induction of DNA synthesis after administration of various tumor promoters is largest after a time perlad of -20 h (19, 20) . In our experiments, we used mice and the interval was only 6.5 h. Therefore, the borderline effect observed with the alpha-isomer might have become more pronounced if a time dependence had been investigated. Additional evidence along these lines is available from two-stage Iangterm carcinogenicity studies with rats where it has been shown that alpha-HCH accelerated the manifestation of malignant liver tumors after initiation of the carcinogenic process by a single dose of diethylnitrosamine (21 ) .
Chemical carcinogens are normally divided into two large classes of mutagenic and non-mutagenic carcinogens (22) . As suggested by Radman and Kinsella (23) there may not be a clear separation of these two groups of activities and it must be expected that there are carcinogens acting on more than only one Ievel. · With HCH, we are faced with a situation where aminute DNA binding was shown for the alpha-and the gammaisomer. Much additional information was given, however, to show that this activity cannot be responsible alone for the tumors induced and some hypotheses were presented and in part supported by experimental data. For a risk evaluation in man, a mutagenic risk by DNA binding after exposure to mg amounts of lindane seems negligible. Although species differences with respect to the formation of reactive metabolites cannot be excluded we do have evidence that binding of gamma-HCH to liver DNA in the rat is sirnilar to the data obtained in mice so that there are at least no indications for large species differences with respect to metabolism. For the more important events not related to DNA binding, an extrapolation of animal data to man must be based upon the elucidation of the specific mechanism of tumor induction by HCH in the animal, and a test of whether similar activities are found in man at dose Ievels that are by orders of magnitude lower than those used in the Iang-term bioassays.
